Accessibility Menu
 
ValiRx Plc logo

ValiRx Plc

(LSE) VAL

Current Price$0.30
Market Cap$230.27M
Since IPO (2006)-100%
5 Year-98%
1 Year-41%
1 Month-7%

ValiRx Plc Financials at a Glance

Market Cap

$230.27M

Revenue (TTM)

$59.38K

Net Income (TTM)

$3.95M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-0.42 (Low)

Price

$0.30

Volume

410,912

Open

$0.30

Previous Close

$0.30

Daily Range

$0.30 - $0.30

52-Week Range

$0.22 - $0.87

VAL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ValiRx Plc

Industry

Biotechnology

CEO

Mark Edward Eccleston, PhD, MBA

Headquarters

Hatfield, CM22 7BD, GB

VAL Financials

Key Financial Metrics (TTM)

Gross Margin

-4%

Operating Margin

-43%

Net Income Margin

-38%

Return on Equity

0%

Return on Capital

-55%

Return on Assets

-45%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$230.27M

Shares Outstanding

742.80M

Volume

410.91K

Short Interest

0.00%

Avg. Volume

4.23M

Financials (TTM)

Gross Profit

$217.22K

Operating Income

$2.14M

EBITDA

$1.86M

Operating Cash Flow

$1.58M

Capital Expenditure

$38.16K

Free Cash Flow

$1.62M

Cash & ST Invst.

$1.56M

Total Debt

$11.86K

ValiRx Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2024YOY CHG

Revenue

$49.77K

N/A

Gross Profit

$83.03K

+29.3%

Gross Margin

-1.67%

N/A

Market Cap

$230.27M

N/A

Market Cap/Employee

$14.39M

N/A

Employees

16

N/A

Net Income

$944.78K

+31.2%

EBITDA

$914.61K

+34.8%

Quarterly Fundamentals

Name
Q4 2024YOY CHG

Net Cash

$512.13K

-40.6%

Accounts Receivable

$64.88K

-67.8%

Inventory

$69.00K

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$6.66K

-44.6%

Return on Assets

-44.95%

N/A

Return on Invested Capital

-54.68%

N/A

Free Cash Flow

$710.98K

+42.1%

Operating Cash Flow

$700.73K

+43.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CIZ.LCizzle Biotechnology Holdings Plc
$2.35+0.00%
GDR.LGenedrive Plc
$0.93-2.63%
FDBK.LFeedback plc
$12.25-2.78%
CRTX.LCRISM Therapeutics Corporation
$11.50+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$10.37+0.10%
INTCIntel
$65.18+0.04%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.81+0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$50.66+0.03%

Questions About VAL

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.